Page last updated: 2024-10-31

nocodazole and Esophageal Neoplasms

nocodazole has been researched along with Esophageal Neoplasms in 1 studies

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research Excerpts

ExcerptRelevanceReference
"Esophageal cancer is a common malignancy with a high mortality rate."1.39Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells. ( Cai, Y; Hu, M; Jiang, F; Liu, C; Liu, Q; Luo, J; Luo, M; Shi, Q; Song, P; Tang, M; Weng, Y; Yang, D; Zhan, X; Zhang, F; Zhang, Y; Zhou, L; Zuo, G, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, M1
Liu, Q1
Song, P1
Zhan, X1
Luo, M1
Liu, C1
Yang, D1
Cai, Y1
Zhang, F1
Jiang, F1
Zhang, Y1
Tang, M1
Zuo, G1
Zhou, L1
Luo, J1
Shi, Q1
Weng, Y1

Other Studies

1 other study available for nocodazole and Esophageal Neoplasms

ArticleYear
Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
    Oncology reports, 2013, Volume: 29, Issue:1

    Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Prolifer

2013